Related references
Note: Only part of the references are listed.In vitro effect of granulocyte-colony stimulating factor and all-trans retinoic acid on the expression of inflammatory cytokines and adhesion molecules in acute promyelocytic leukemic cells
Hui-Chi Hsu et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Use of All-trans Retinoic Acid in Combination with Arsenic Trioxide for Remission Induction in Patients with Newly Diagnosed Acute Promyelocytic Leukemia and for Consolidation/Maintenance in CR Patients
Chong-Wen Dai et al.
ACTA HAEMATOLOGICA (2009)
Reversible cardiac dysfunction without myocytolysis related to all-trans retinoic acid administration during induction therapy of acute promyelocytic leukemia
Annunziata Manna et al.
ANNALS OF HEMATOLOGY (2009)
Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia
Anne Saumet et al.
BLOOD (2009)
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors
Pau Montesinos et al.
BLOOD (2009)
Auto-SCT for AML in second remission: CALGB Study 9620
C. A. Linker et al.
BONE MARROW TRANSPLANTATION (2009)
Improved Outcome of Acute Promyelocytic Leukemia With High WBC Counts Over the Last 15 Years: The European APL Group Experience
Charikleia Kelaidi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin
Farhad Ravandi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
Jiong Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia
Christopher C. Dvorak et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy
Wing-Yan Au et al.
BLOOD (2008)
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin
Javier de la Serna et al.
BLOOD (2008)
Acute promyelocytic leukemia: from highly fatal to highly curable
Zhen-Yi Wang et al.
BLOOD (2008)
Entry of elemental arsenic into the central nervous system in patients with acute promyelocytic leukemia during arsenic trioxide treatment
Wing-Yan Au et al.
LEUKEMIA RESEARCH (2008)
Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
Rihab Nasr et al.
NATURE MEDICINE (2008)
High incidence of acute promyelocytic leukemia in children in northwest Italy, 1980-2003: a report from the Childhood Cancer Registry of Piedmont
M. M. Maule et al.
LEUKEMIA (2008)
Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines
Rafael Henriques Jacomo et al.
HAEMATOLOGICA (2007)
Impact of FLT3 mutations and secondary cytogenetic changes on the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with a single agent arsenic trioxide regimen
Vikram Mathews et al.
HAEMATOLOGICA (2007)
A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARα transcript after consolidation therapy:: The Japan Adult Leukemia Study Group (JALSG) APL97 study
Norio Asou et al.
BLOOD (2007)
Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome
Masamitsu Yanada et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Sustained molecular remission after low dose gemtuzumab-ozogamicin in elderly patients with advanced acute promyelocytic leukemia
Massimo Breccia et al.
HAEMATOLOGICA (2007)
Sweet's syndrome-like neutrophilic lobular panniculitis associated with all-trans-retinoic acid chemotherapy in a patient with acute promyelocytic leukemia
Jared Jagdeo et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline-based chemotherapy:: the European APL group experience (APL 91 and APL 93 trials)
C Kelaidi et al.
LEUKEMIA (2006)
Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity
V Mathews et al.
BLOOD (2006)
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
S de Botton et al.
LEUKEMIA (2006)
Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy
A Ghavamzadeh et al.
ANNALS OF ONCOLOGY (2006)
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia
RE Gale et al.
BLOOD (2005)
GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children
AM Testi et al.
BLOOD (2005)
Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: A retrospective analysis of the European acute promyelocytic leukemia group
S de Botton et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia - a single center experience in 34 patients
N Dally et al.
THROMBOSIS RESEARCH (2005)
Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy:: a multicenter study by the PETHEMA group
MA Sanz et al.
BLOOD (2004)
Treatment of children with newly diagnosed acute promyelocytic leukemia with arsenic trioxide: a single center experience
B George et al.
LEUKEMIA (2004)
Immunofluorescent analysis with the anti-PML monoclonal antibody PG-M3 for rapid and accurate genetic diagnosis of acute promyelocytic leukemia
F Gomis et al.
ANNALS OF HEMATOLOGY (2004)
Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia
F Lo-Coco et al.
BLOOD (2004)
Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience
I Lobe et al.
LEUKEMIA (2003)
Functional p85α gene is required for normal murine fetal erythropoiesis
H Huddleston et al.
BLOOD (2003)
Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia
E Raffoux et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial
S de Botton et al.
LEUKEMIA (2003)
Early detection of meningeal localization in acute promyelocytic leukaemia patients with high presenting leucocyte count
M Breccia et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia
D Grimwade et al.
LEUKEMIA (2002)
Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience
A Pulsoni et al.
BLOOD (2002)
Anthracycline-related toxicity requiring cardiac transplantation in long-term disease-free survivors with acute promyelocytic leukemia
X Thomas et al.
ANNALS OF HEMATOLOGY (2002)
Experience with gemtuzumab ozogamycin (mylotarg), and all-trans retinoic acid in untreated acute promyelocytic leukemia
EH Estey et al.
BLOOD (2002)
Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report
DP Lu et al.
BLOOD (2002)
Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring
K Ohnishi et al.
LEUKEMIA (2002)
Therapy-related myelodysplastic syndrome-acute myelogenous leukemia in patients treated for acute promyelocytic leukemia: an emerging problem
R Latagliata et al.
BLOOD (2002)
Sweet's syndrome associated with retinoic acid syndrome in a patient with promyelocytic leukemia
L Astudillo et al.
ANNALS OF HEMATOLOGY (2002)
Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid:: A report by the Gruppo Italiano Malattie Ematologiche dell'Adulto
G Specchia et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
SL Soignet et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid:: effects in patients with newly diagnosed acute promyelocytic leukemia
E Lengfelder et al.
LEUKEMIA (2000)
Hypergranular promyelocytic leukemia: correlation between morphology and chromosomal translocations including t(15;17) and t(11;17)
JM Bennett et al.
LEUKEMIA (2000)
Diffuse alveolar hemorrhage in acute promyelocytic leukemia patients treated with ATRA - A manifestation of the basic disease or the treatment
P Raanani et al.
LEUKEMIA & LYMPHOMA (2000)
Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia
E Di Bona et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
